ArticleClinical & experimental metastasis2025
Prognostic immunotherapy score (PIS) in patients with advanced urothelial carcinoma treated with pembrolizumab: real-world data and validation from ARON-2 dataset.
Alessandro Rizzo et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it